Scholarlink

<p>In South Korea, the traditional use of Korean medicine is recognized by the government, with efforts being made to expand its inclusion in health insurance. However, unlike pharmaceutical drugs, traditional medicines are used in clinical practice without proper non-clinical and clinical trial validation, raising criticism and concerns. Mangeum-tang is commonly used for treating sequelae from stroke and neuralgia. The rhizome of <i>Cnidium officinale</i> MAKINO, included in Mangeum-tang, is known to reduce embryonic growth and development in rats and induce mild limb malformations, raising safety concerns. The causes of malformations are diverse, often linked to genotoxicity, prompting toxicity investigations. In vitro, Mangeum-tang did not induce genetic mutations or chromosomal aberration, and in vivo, it did not cause micronucleus formation or acute toxicity in hematopoietic cells. Therefore, Mangeum-tang does not appear to induce acute toxicity or genotoxicity. However, the studies conducted were short-term, and toxicity from repeated administration has not been confirmed. To ensure the safety of Mangeum-tang, further studies, including repeated-dose toxicity tests, carcinogenicity tests, reproductive toxicity tests, and additional research on the genotoxicity of <i>Cnidium officinale</i> MAKINO, are necessary.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Non-clinical safety evaluation of Mangeum-tang

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月6日

查看全文
  • Sung-min Hwang,
  • Sung-young Jo,
  • Su-yeong Kim,
  • Jun-sub Kim,
  • Hyun-woo Cho,
  • Jong-Hyun Nho

摘要

In South Korea, the traditional use of Korean medicine is recognized by the government, with efforts being made to expand its inclusion in health insurance. However, unlike pharmaceutical drugs, traditional medicines are used in clinical practice without proper non-clinical and clinical trial validation, raising criticism and concerns. Mangeum-tang is commonly used for treating sequelae from stroke and neuralgia. The rhizome of Cnidium officinale MAKINO, included in Mangeum-tang, is known to reduce embryonic growth and development in rats and induce mild limb malformations, raising safety concerns. The causes of malformations are diverse, often linked to genotoxicity, prompting toxicity investigations. In vitro, Mangeum-tang did not induce genetic mutations or chromosomal aberration, and in vivo, it did not cause micronucleus formation or acute toxicity in hematopoietic cells. Therefore, Mangeum-tang does not appear to induce acute toxicity or genotoxicity. However, the studies conducted were short-term, and toxicity from repeated administration has not been confirmed. To ensure the safety of Mangeum-tang, further studies, including repeated-dose toxicity tests, carcinogenicity tests, reproductive toxicity tests, and additional research on the genotoxicity of Cnidium officinale MAKINO, are necessary.